BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DSKI - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DSKI
X-ORIGINAL-URL:https://dski.dk
X-WR-CALDESC:Events for DSKI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190913
DTEND;VALUE=DATE:20190916
DTSTAMP:20260915T174323
CREATED:20190422T182637Z
LAST-MODIFIED:20190422T182637Z
UID:9688-1568332800-1568591999@dski.dk
SUMMARY:ICLE 2019: International Conference on Lymphocyte Engineering 2019
DESCRIPTION:The second International Conference on Lymphocyte Engineering (ICLE 2019)\, will take place in London\, on 13-15 September 2019. \nICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations\, deepening the connection between basic and clinical research across related disease specialties: oncology\, pathogenic diseases\, autoimmunity\, immunodeficiencies and others. \nThe Chair of the Conference is Dr. Adi Barzel. The impressive line-up of speakers include Prof. Carl June\, Prof. Stanley Riddel\, Prof. Nicholas Restifo\, Prof. Waseem Qasim\, Prof. John Anderson\, Prof. Hans Stauss and a lot more – https://lymphocyte.kenes.com/speakers/ \nProgramme highlights include: \n\nLymphocyte engineering for the treatment of Hematological malignancies\nLymphocyte engineering for the treatment of Solid Tumors\nGenome editing for allogeneic ACT\nSafety switches & controlled expression\nEngineering HSC\, NK\, NKT and γδ T cells\nTarget & receptor discovery\nLymphocyte engineering for the treatment of HIV\nOptimizing receptor and vector design\nNon-viral vectors and transposons\n\n  \nWith ground-breaking clinical success and exponentially growing research leading to FDA approved products\, lymphocyte engineering is the way of the future. Be part of it! \nJoin us for the 2nd International Conference on Lymphocyte Engineering – where the world`s health innovators in immuno-gene therapy come together. \nAbstract Submission Deadline: 22 May 2019 \nEarly Registration Deadline: 19 June 2019 \n 
URL:https://dski.dk/begivenhed/icle-2019-international-conference-on-lymphocyte-engineering-2019/
END:VEVENT
END:VCALENDAR